| 2024-03-18 | Sale | AbbVie Inc. ABBV | EVP, CHIEF COMMERCIAL OFFICER | 58,949 0.0033% | $178.79 | $10.54M | -6.76% | |
| 2023-03-13 | Sale | AbbVie Inc. ABBV | 53,125 0.003% | $152.28 | $8.09M | +0.29% | ||
| 2022-03-24 | Sale | AbbVie Inc. ABBV | EVP, Chief Commercial Officer | 27,690 0.0016% | $159.20 | $4.41M | -4.15% | |
| 2022-03-01 | Sale | AbbVie Inc. ABBV | EVP, Chief Commercial Officer | 21,488 0.0012% | $148.25 | $3.19M | +3.79% | |
| 2021-12-15 | Sale | AbbVie Inc. ABBV | EVP, Chief Commercial Officer | 2,152 0.0001% | $128.00 | $275,456 | +15.41% | |
| 2021-03-01 | Sale | AbbVie Inc. ABBV | SVP, US Commercial Operations | 13,773 0.0008% | $108.59 | $1.5M | +8.51% | |
| 2020-12-29 | Sale | AbbVie Inc. ABBV | EVP, Commercial Operations | 25,290 0.0015% | $105.00 | $2.66M | +9.86% | |
| 2020-05-12 | Sale | AbbVie Inc. ABBV | SVP, US Commercial Operations | 23,024 0.0013% | $90.00 | $2.07M | +11.68% | |
| 2019-08-16 | AbbVie Inc. ABBV | SVP, US Commercial Operations | 31,104 0.0021% | $64.44 | $2M | +37.99% |